A detailed history of Td Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Td Asset Management Inc holds 1,231,185 shares of ABT stock, worth $144 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,231,185
Previous 1,263,016 2.52%
Holding current value
$144 Million
Previous $131 Million 6.96%
% of portfolio
0.13%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$100.07 - $118.13 $3.19 Million - $3.76 Million
-31,831 Reduced 2.52%
1,231,185 $140 Million
Q2 2024

Aug 02, 2024

SELL
$100.73 - $112.44 $81,792 - $91,301
-812 Reduced 0.06%
1,263,016 $131 Million
Q1 2024

May 08, 2024

SELL
$109.52 - $120.96 $6.34 Million - $7.01 Million
-57,929 Reduced 4.38%
1,263,828 $144 Million
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $69.1 Million - $84.6 Million
-765,909 Reduced 36.69%
1,321,757 $145 Million
Q3 2023

Oct 27, 2023

SELL
$95.53 - $114.62 $26.4 Million - $31.6 Million
-276,094 Reduced 11.68%
2,087,666 $202 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $40.6 Million - $45.3 Million
403,201 Added 20.57%
2,363,760 $258 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $45.1 Million - $53 Million
-465,229 Reduced 19.18%
1,960,559 $199 Million
Q4 2022

Feb 06, 2023

SELL
$95.06 - $111.52 $61.1 Million - $71.7 Million
-642,872 Reduced 20.95%
2,425,788 $266 Million
Q3 2022

Nov 07, 2022

SELL
$96.76 - $112.03 $79 Million - $91.5 Million
-816,547 Reduced 21.02%
3,068,660 $302 Million
Q2 2022

Aug 04, 2022

BUY
$102.07 - $123.37 $2.46 Million - $2.97 Million
24,068 Added 0.62%
3,885,207 $422 Million
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $22.9 Million - $28 Million
201,126 Added 5.5%
3,861,139 $457 Million
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $20.4 Million - $25 Million
176,650 Added 5.07%
3,660,013 $515 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $1.04 Million - $1.15 Million
8,931 Added 0.26%
3,483,363 $411 Million
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $57.4 Million - $67.6 Million
542,653 Added 18.51%
3,474,432 $420 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $19.3 Million - $22.7 Million
177,151 Added 6.43%
2,931,779 $351 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $38.2 Million - $41.7 Million
-364,031 Reduced 11.67%
2,754,628 $302 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $302,228 - $367,034
3,298 Added 0.11%
3,118,659 $339 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $20.3 Million - $26 Million
-264,921 Reduced 7.84%
3,115,361 $285 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $72.7 Million - $106 Million
1,156,709 Added 52.02%
3,380,282 $267 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $4.73 Million - $5.27 Million
60,290 Added 2.79%
2,223,573 $193 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $6.87 Million - $7.45 Million
83,974 Added 4.04%
2,163,283 $181 Million
Q2 2019

Aug 01, 2019

BUY
$72.88 - $85.0 $3.55 Million - $4.14 Million
48,706 Added 2.4%
2,079,309 $175 Million
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $11.1 Million - $13.4 Million
167,444 Added 8.99%
2,030,603 $162 Million
Q4 2018

Feb 01, 2019

BUY
$65.56 - $74.27 $7.62 Million - $8.64 Million
116,288 Added 6.66%
1,863,159 $135 Million
Q3 2018

Nov 01, 2018

SELL
$60.81 - $73.36 $1.78 Million - $2.15 Million
-29,283 Reduced 1.65%
1,746,871 $128 Million
Q2 2018

Jul 31, 2018

BUY
$57.57 - $63.54 $15.6 Million - $17.2 Million
270,225 Added 17.94%
1,776,154 $108 Million
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $1.9 Million - $2.15 Million
33,729 Added 2.29%
1,505,929 $90.2 Million
Q4 2017

Feb 02, 2018

SELL
$53.68 - $57.47 $2.22 Million - $2.38 Million
-41,407 Reduced 2.74%
1,472,200 $84 Million
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $72.7 Million - $81.2 Million
1,513,607
1,513,607 $80.8 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.